Monthly Archives: November 2023

AI tools may be effective at detecting heart valvular disease and predicting cardiovascular risk

Advances in artificial intelligence have enabled the development and application of AI tools that may be effective at detecting heart valvular disease and predicting the risk of cardiovascular disease events, according to preliminary research in two studies to be presented at the American Heart Association’s Scientific Sessions 2023. The meeting, to be held Nov. 11-13, […]

Infection Control Today Exclusive: The Challenge of Health Care-Associated Infections (HAIs) and Evolving Prevention: A Focus on Hand Hygiene

Hand hygiene (Adobe Stock 417724081 by Roman) Health care-associated infection (HAI) is one of the biggest public health problems that the United States is now dealing with. According to the Agency for Healthcare Research and Quality, HAIs are the most common complication of hospital care and are one of the top 10 leading causes of […]

Maribavir Offers Another Treatment for CMV Infections Post-Transplant

Transplantation patients can be challenging to treat, especially with the introduction of a new organ or living tissue into the body and dealing with all the potential side effects including infections. For example, the development of cytomegalovirus (CMV) in post-transplant patients can bring about a whole host of issues. “Once [clinicians] do identify that there’s […]

Bristol Myers buys Orum’s blood cancer therapy for up to $180 mln

Companies Bristol-Myers Squibb Co Follow Orum Therapeutics, Inc. Follow Nov 6 (Reuters) – Bristol Myers Squibb (BMY.N) has acquired Orum Therapeutics’ experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. The therapy, ORM-6151, which helps degrade a specific protein […]

Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023

New clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS ® (mavacamten) for patients with symptomatic obstructive HCM PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that research across the company’s cardiovascular franchise will be presented at the American Heart Association’s (AHA) annual Scientific Sessions, taking place November […]

18 units collected last week during LifeServe community blood drive in Blunt

NOVEMBER 6, 2023: LifeServe Blood Center held a blood drive in Blunt on Thursday, November 2, 2023, with 16 individuals registered to donate. 14 donors were able to donate, and 18 units of life saving blood were collected. The units donated at the blood drive can help up to 58 lives patients. There was one […]

Problems with the menstrual cycle may raise a woman’s risk of cardiovascular disease

The primary cause of death for women is cardiovascular disease, which includes heart disease and vascular diseases, including high blood pressure. Nearly 45% of women 20 years and older have a cardiovascular disease, according to the American Heart Association‘s Heart Disease and Stroke Statistics-2023 Update. Reducing the risk of heart disease in young women would […]

Exploring the connection: Diet, sleep patterns, and blood pressure in young individuals

In a recent study published in Hypertension Research, a group of researchers examined the relationship between dietary and sleep rhythms and blood pressure (BP) levels in children aged 6-15 from Chongqing and Sichuan provinces and identified optimal rhythm interventions to prevent Cardiovascular diseases (CVD) onset potentially. Study: The impact of dietary and sleep rhythms on blood […]